Author

B J Lipworth

Institutions: Northwestern University, University of Dundee, Ninewells Hospital

Observed institutions: Northwestern University, University of Dundee, Ninewells Hospital

OpenAlex ID: A5136367107

B22-12 Effect of Tezepelumab on Type 2 Inflammatory Biomarker Levels in the Nasal Lining Fluid of Patients With CRSwNP and Comorbid Asthma

2026 · B J Lipworth, C Marchese, et al. · American Journal of Respiratory and Critical Care Medicine

B32-14 Real-world Comparative Effectiveness of Dupilumab vs. Tezepelumab on Asthma Exacerbations: A US Claims Analysis

2026 · G Mosnaim, T A Doherty, et al. · American Journal of Respiratory and Critical Care Medicine

B29-17 Albuterol-budesonide Treatment for Acute Airway Obstruction Provides Enhanced Lung Function Improvement Compared to Albuterol in Mild Asthma Irrespective of Baseline Forced Expiratory Volume in One-second (FEV1)

2026 · R A Panettieri, B J Lipworth, et al. · American Journal of Respiratory and Critical Care Medicine

Wirksamkeit von Tezepelumab bei Erwachsenen mit schwerer, unkontrollierter chronischer Rhinosinusitis mit Nasenpolypen als Teil einer Samter-Trias (WAYPOINT)

2026 · O Pfaar, B J Lipworth, et al. · Pneumologie

Dupilumab Versus Omalizumab: Greater Lung Function Improvements in Patients With Chronic Rhinosinusitis With Nasal Polyps and Uncontrolled Asthma (EVEREST) With Dupilumab

2026 · J Oppenheimer, M Wagenmann, et al. · Pneumologie

Tezepelumab reduzierte die Entzündungsbiomarker bei Erwachsenen mit schwerer chronischer Rhinosinusitis mit Nasenpolypen mit oder ohne Asthma: Ergebnisse aus der Phase 3 Studie WAYPOINT

2026 · O Pfaar, B J Lipworth, et al. · Pneumologie

Works count: 6

Citation count:

H-index:

I10-index: